Copyright
©The Author(s) 2026.
World J Clin Cases. Jan 6, 2026; 14(1): 115102
Published online Jan 6, 2026. doi: 10.12998/wjcc.v14.i1.115102
Published online Jan 6, 2026. doi: 10.12998/wjcc.v14.i1.115102
Table 1 Routine laboratory examination findings taken at the outpatient department
| Parameter (unit) | Measured value | Normal value |
| White blood cells (103/µL) | 14.1 | 3.9-9.7 |
| Neu (%) | 92 | 37-72 |
| Lym (%) | 2 | 25-48 |
| Mon (%) | 5 | 2-12 |
| Eos (%) | 0 | 1-9 |
| Bas (%) | 1 | 0-2 |
| Hemoglobin (g/dL) | 10.2 | 13.4-17.1 |
| Platelets (103/µL) | 263 | 153-346 |
| Aspartate transaminase (IU/L) | 14 | 5-37 |
| Alanine aminotransferase (IU/L) | 6 | 6-43 |
| Lactic acid dehydrogenase (U/L) | 235 | 124-222 |
| Alkaline phosphatase (U/L) | 104 | 38-113 |
| Gamma-glutamyl transpeptidase (IU/L) | 29 | 0-75 |
| Total bilirubin (mg/dL) | 0.7 | 0.4-1.2 |
| Total protein (g/dL) | 6.7 | 6.5-8.5 |
| Albumin (g/dL) | 3.3 | 3.8-5.2 |
| Creatine kinase (U/L) | 18 | 57-240 |
| Blood urea nitrogen (mg/dL) | 19 | 9-21 |
| Creatinine (mg/dL) | 3.38 | 0.6-1 |
| Amylase (IU/L) | 24 | 43-124 |
| Sodium (mEq/L) | 135 | 135-145 |
| Potassium (mEq/L) | 4 | 3.5-5 |
| Chloride (mEq/L) | 102 | 96-107 |
| Calcium (mg/dL) | 9.5 | 8.5-10.2 |
| Inorganic phosphorus (mg/dL) | 2.7 | 2-4.5 |
| C-reactive protein (mg/dL) | 19.76 | 0-0.29 |
| Plasma glucose (mg/dL) | 82 | 65-109 |
| Glycosylated hemoglobin A1c (NGSP) (%) | 4.8 | 4.6-6.2 |
| Activated partial thromboplastin time (seconds) | 63.2 | 23-36 |
| Prothrombin time (International normalized ratio) | 2.04 | 0.85-1.15 |
| Fibrinogen and fibrin degradation products (μg/mL) | 41.9 | 0-10 |
Table 2 Ascites findings taken at the outpatient department
| Parameter (unit) | Measured value |
| Appearance | Pale blooded |
| Total protein (g/dL) | 4.4 |
| Albumin (g/dL) | 2.3 |
| Glucose (mg/dL) | 46 |
| Lactate dehydrogenase (U/L) | 293 |
| Cell count (103/µL) | 16.9 |
| Mononuclear cell (103/µL) | 1.7 |
| Neutrophilic cell (103/µL) | 15.2 |
Table 3 Results of antimicrobial susceptibility testing of ascites taken at the outpatient department
| Antibiotics | MIC | Sensitivity |
| Ampicillin | < 8 | S |
| Ampicillin/sulbactam | < 8 | S |
| Piperacillin | < 8 | S |
| Piperacillin/tazobactam | < 16 | S |
| Cefazolin | < 4 | S |
| Cefaclor | < 8 | S |
| Cefotiam | < 8 | S |
| Cefmetazole | < 8 | S |
| Flomoxef | < 8 | S |
| Cefoperazone/sulbactam | < 16 | S |
| Cefotaxime | < 1 | S |
| Ceftazidime | < 4 | S |
| Ceftriaxone | < 1 | S |
| Cefepime | < 2 | S |
| Cefcapene | < 0.25 | S |
| Imipenem/cilastatin | < 1 | S |
| Meropenem | < 1 | S |
| Aztreonam | < 4 | S |
| Gentamicin | < 2 | S |
| Amikacin | < 4 | S |
| Minocycline | < 2 | S |
| Levofloxacin | < 0.5 | S |
| Fosfomycin | < 4 | S |
| Sulfamethoxazole-trimethoprim | < 2 | S |
- Citation: Usuda D, Furukawa D, Imaizumi R, Ono R, Kaneoka Y, Nakajima E, Kato M, Sugawara Y, Shimizu R, Inami T, Kawai K, Matsubara S, Tanaka R, Suzuki M, Shimozawa S, Hotchi Y, Osugi I, Katou R, Ito S, Mishima K, Kondo A, Mizuno K, Takami H, Komatsu T, Nomura T, Sugita M. Spontaneous bacterial peritonitis due to Edwardsiella tarda in an immuno-compromised dialysis patient: A case report and review of literature. World J Clin Cases 2026; 14(1): 115102
- URL: https://www.wjgnet.com/2307-8960/full/v14/i1/115102.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v14.i1.115102
